- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01489449
Bare Metal Stent Versus Drug Coated Balloon With Provisional Stenting in Non-ST-Elevation Myocardial Infarction (PEPCADNSTEMI)
May 2, 2023 updated by: University Hospital, Saarland
The aim of the present trial is to assess the efficacy of the standalone use of SeQuent(R) Please coated balloon compared to a bare metal stent (BMS) in patients with NSTEMI.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of the present trial is to assess the efficacy of the standalone use of SeQuent(R) Please coated balloon compared to a bare metal stent (BMS) in patients with NSTEMI.
Primary efficacy endpoint will be MACE (cardiac mortality, reinfarction, and target lesion revascularization) after 9 months.
Study Type
Interventional
Enrollment (Actual)
210
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saarland
-
Homburg/Saar, Saarland, Germany, 66421
- Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- NSTEMI with
- Ischemic symptoms (angina pectoris) > 30 minutes
- Last symptoms within 72 hours before randomization
- Positive cardiac troponin T, I, or hs-Troponin above 99th percentile
- age > 18 years
- Identifiable culprit lesion without angiographic evidence of large thrombus with intended early PCI (treatment of up to two lesions allowed)
Exclusion Criteria:
- Cardiogenic shock
- ST-elevation myocardial infarction
- No identifiable culprit lesion, Indication for acute bypass surgery
- Comorbidity with limited life expectancy < 9-12 months
- Contraindication for treatment with heparin, ASA and thienopyridines
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Stent
Stent Implantation (DES or BMS), no further treatment
|
bare metal stent implantation, any bare metal stent is allowed from different companies
|
Active Comparator: DCB
"DEBonly" strategy: treatment with drug coated balloon, additional spot-stenting in case of severe dissection
|
Angioplasty with Drug coated balloon (DCB)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MACE
Time Frame: 9 months
|
MACE means the occurence of cardiac death, reinfarction, or target lesion revascularization
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Stent thrombosis (ARC
Time Frame: 9 months, 3 years, 5 years
|
9 months, 3 years, 5 years
|
Mortality (cardiac and non-cardiac)
Time Frame: 9 months, 3 years, 5 years
|
9 months, 3 years, 5 years
|
Reinfarction
Time Frame: 9 months, 3 years, 5 years
|
9 months, 3 years, 5 years
|
target lesion revascularization
Time Frame: 9 months, 3 years, 5 years
|
9 months, 3 years, 5 years
|
target vessel revascularization
Time Frame: 9 months, 3 years, 5 years
|
9 months, 3 years, 5 years
|
any revascularization
Time Frame: 9 months, 3 years, 5 years
|
9 months, 3 years, 5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bruno Scheller, MD, Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2012
Primary Completion (Actual)
June 23, 2018
Study Completion (Actual)
June 23, 2022
Study Registration Dates
First Submitted
November 27, 2011
First Submitted That Met QC Criteria
December 7, 2011
First Posted (Estimate)
December 9, 2011
Study Record Updates
Last Update Posted (Estimate)
May 4, 2023
Last Update Submitted That Met QC Criteria
May 2, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEPCAD NSTEMI
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Heart Disease
-
Peking University Third HospitalCompletedCoronary Microvascular Dysfunction | Obstructive Coronary Heart DiseaseChina
-
Centro de estudios en Cardiologia IntervencionistaCompletedCoronary Heart Disease | Coronary RestenosisArgentina
-
Deutsches Herzzentrum MuenchenCompletedCoronary Heart DiseaseGermany
-
Henan Institute of Cardiovascular EpidemiologyNot yet recruitingStable Coronary Heart Disease
-
Astana Medical UniversityCompletedCHD - Coronary Heart DiseaseKazakhstan
-
Second Affiliated Hospital, School of Medicine,...RenJi HospitalUnknown
-
Xiyuan Hospital of China Academy of Chinese Medical...UnknownStable Coronary Heart DiseaseChina
-
Charite University, Berlin, GermanyCompletedStable Coronary Heart DiseaseGermany
-
Duke UniversityCompletedCoronary Heart Disease Risk
-
City Hospital No 40, Saint Petersburg, RussiaWithdrawnCoronary Heart Disease (CHD)
Clinical Trials on Stent
-
Zhujiang HospitalNanfang Hospital of Southern Medical University; Guangdong Provincial People...UnknownTrials of Clinical Curative Effect, Follow-up Study and Hemodynamics of Treatment of IA Using StentsTreatment Outcome by Stent-assisted EmbolizationChina
-
Royal Sussex County HospitalTerumo CorporationCompletedCoronary DiseaseUnited Kingdom
-
Southeast University, ChinaUnknownEsophageal CancerChina
-
Baylor College of MedicineEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsTerminatedVaginal StrictureUnited States
-
Merit Medical Systems, Inc.CompletedVenous Stenosis | Venous OcclusionUnited Kingdom, Greece
-
UMC UtrechtUnknownAcute Coronary Syndrome | Stable Angina PectorisNetherlands, Luxembourg
-
Medinol Ltd.CompletedIschemic Heart DiseaseIsrael, Sweden, Belgium, Germany
-
Chang Gung Memorial HospitalNot yet recruitingVascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation LesionsCoronary Artery DiseaseTaiwan
-
Yonsei UniversityUnknownColorectal CancerKorea, Republic of
-
Biotronik, Inc.CompletedPeripheral Vascular Disease | Peripheral Artery DiseaseCanada, United States